Hormone Receptor-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Hormone Receptor-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies [Phase 2]
A Phase 2 trial update from UNC Lineberger Comprehensive Cancer Center for biomarker-driven therapies in breast cancer, currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer [Phase 2]
This Clinical Trials update describes the I-SPY TRIAL, a Phase 2 neoadjuvant breast cancer study using personalized adaptive agents; recruit…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Onvansertib + Paclitaxel In TNBC [Phase 1, Phase 2]
This document reports an ongoing Phase 1/2 clinical trial evaluating the combination of onvansertib with paclitaxel in patients with triple-…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC [Phase 1, Phase 2]
Phase 1/2 clinical trial of ZN-c3 combined with carboplatin and pembrolizumab for metastatic triple-negative breast cancer, currently listed…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy [Phase 2]
Phase 2 neoadjuvant breast cancer trial at Fudan University Shanghai Cancer Center evaluating a precision-platform therapy; the study is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer [Phase 3]
A Phase 3 trial compares HLX11 to EU-Perjeta (pertuzumab) as neoadjuvant therapy for HER2-positive, hormone receptor-negative breast cancer.…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO [Phase 2]
Phase 2 trial comparing a CDK4/6 inhibitor with endocrine therapy to chemotherapy with endocrine therapy in advanced/metastatic breast cance…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) [Phase 1]
Phase 1 trial update for BN-Brachyury, Entinostat, Adotrastuzumab Emtansine, and M7824 in advanced breast cancer; trial status terminated wi…